References
- Cancer in Slovenia 2015 Ljubljana: Institute of Oncology Ljubljana, Epidemiology and Cancer Registry, Cancer Registry of Republic of Slovenia; 2018.
- Hočevar M. Klinični registri v onkologiji. Onkologija 2011; 15: 14-7.
- Clinical register of skin melanoma. In Cancer Registry of Republic of Slovenia, editor. Epidemiology and Cancer Registry. [cited 2019 Jan 15]. Available at: https://www.onko-i.si/eng/
- Takač I, Ferletič M, Arko D, Gorišek B. Follow-up computer program for patients with ovarian malignancy In: Bigec M, Lavrenčič D, Kokol P, editors. Zbornik referatov II del. Inform Med Slov Print 1996; 3: 43-6.
- Takač I, Gorišek B. User friendly inquiry and computer program for following patients with ovarian malignancy. Arch Gynecol Obstet 1999; 263: 60-7. PMID: 10728632
- Collaborative Group on Hormonal Factors in Breast Cancer. Familial breast cancer: collaborative reanalysis of individual data from 52 epidemiological studies including 58 209 women with breast cancer and 101 986 women without the disease. Lancet 2001; 358: 1389-99. doi: 10.1016/S0140-6736(01)06524-2
- Brewer HR, Jones ME, Schoemaker MJ, Ashworth A, Swerdlow AJ. Family history and risk of breast cancer: an analysis accounting for family structure. Breast Cancer Res Treat 2017; 165: 193-200. doi: 10.1007/s10549-017-4325-2
- Clavel-Chapelon F, Gerber M. Reproductive factors and breast cancer risk. Do they differ according to age at diagnosis? Breast Cancer Res Treat 2002; 72: 107-15. PMID: 12038701
- Chowdhury R, Sinha B, Sankar MJ, Taneja S, Bhandari N, Rollins N, et al. Breastfeeding and maternal health outcomes: a systematic review and meta-analysis. Acta Paediatr 2015; 104: 96-113. doi: 10.1111/apa.13102
- Mørch LS, Skovlund CW, Hannaford PC, Iversen L, Fielding S, Lidegaard Ø. Contemporary hormonal contraception and the risk of breast cancer. N Eng J Med 2017; 377: 2228-39. doi: 10.1056/NEJMoa1700732
- Jones ME, Schoemaker MJ, Wright L, McFadde E, Griffin J, Thomas D, et al. Menopausal hormone therapy and breast cancer: what is the true size of the increased risk? Br J Cancer 2016; 115: 607-15. doi: 10.1038/ bjc.2016.231
- Lerner-Geva L, Rabinovici J, Olmer L, Blumstein T, Mashiach S, Lunenfeld B. Are infertility treatments a potential risk factor for cancer development? Perspective of 30 years of follow-up. Gynecol Endocrinol 2012; 10: 809-14. doi: 10.3109/09513590.2012.671391
- Cetin I, Cozzi V, Antonazzo P. Infertility as a cancer risk factor - a review. Placenta 2008; 29(Suppl B): 169-77. doi: 10.1016/j.placenta.2008.08.007
- Castburg C, Miller AB, Rohan TE. Active cigarette smoking and risk of breast cancer. Int J Cancer 2015; 136: 2204-9. doi: 10.1002/ijc.29266
- Liu Y, Nguyen N, Colditz GA. Links between alcohol consumption and breast cancer: a look at the evidence. Womens Health (Lond) 2015; 1: 65-77. doi: 10.2217/whe.14.62
- Munsell MF, Sprague BL, Berry DA, Chisholm G, Trentham-Dietz A. Body mass index and breast cancer risk according to postmenopausal estrogen-progestin use and hormone receptor status. Epidem Rev 2014; 36: 114-36. doi: 10.1093/epirev/mxt010
- Žgajnar J, Marinko T, Šeruga B. Rak dojk. In Strojan P, Hočevar M, editors Onkologija [cited 2019 Jan 15]. Available at: www.onko-i.si/ucbenik_onkologija Ljubljana 2018. p. 508-37.
- Güth U, Magaton I, Huang DJ, Fisher R, Schötzau A, Vette M. Primary and secondary distant metastatic breast cancer: two sides of the same coin. Breast 2014; 23: 26-32. doi: 10.1016/j.breast.2013.10.007
- Provencer L, Hogue JC, Desbiens C, Poirier B, Poirier E, Bodreau D, et al. Is clinical examination important for breast cancer detection? Curr Oncol 2016; 4: 332-9. doi: 10.3747/co.23.2881
- Kim GR, Choi JS, Han BK, Lee JE, Nan SJ, Ko EY, et al. Preoperative axillary US in early-stage breast cancer: potential to prevent unnecessary axillary lymph node dissection. Radiology 2018; 288: 55-63. doi: 10.1148/ radiol.2018171987
- Ibrahim-Zada I, Grant CS, Glazebrooke KN, Boughey JC. Preoperative axillary ultrasound in breast cancer: safely avoiding frozen section of sentinel lymph nodes in breast conserving surgery. J Am Coll Surg 2013; 217: 7-15. doi: 10.1016/j.jamcollsurg.2013.01.064
- Blatnik A, Perhavec A, Gazić B, Vidergar-Kralj B, Matos E, Ratoša I, et al. [Guidelines for diagnosis and treatment of breast cancer]. [Slovenian]. Ljubljana: Institute of Oncology Ljubljana, 2018. [cited 2019 Jan 15]. Available at: https://www.onko-i.si/fileadmin/onko/datoteke/Smernice/Smernice_diagnostike_in_zdravljenja_raka_dojk_2018.pdf
- O’Halloran N, Lowery A, Kalinina O, Sweeney K, Malone C, McLoughlin R, et al. Trends in breast reconstruction practices in a specialized breast tertiary referral centre. BJS Open 2017; 5: 148-57. doi: 10.1002/bjs5.23
- Platt J, Baxter N, Zhong T. Breast reconstruction after mastectomy for breast cancer. CMAJ 2011; 18: 2109-16. doi: 10.1503/cmaj.110513
- Moschetta M, Telegrafo M, Carluccio DA, Jablonska JP, Rella L, Serio G, et al. Comparison between fine needle aspiration cytology (FNAC) and core biopsy (CNB) in the diagnostic of breast. G Chir 2014; 35: 171-6. PMID: 25174291
- Wang M, He X, Chang Y, Sun G, Thabane L. A sensitivity and specific comparison of fine needle aspiration cytology and core needle biopsy in evaluation of suspicious breast lesion: a systematic review and meta-analysis. Breast 2017; 31: 157-66. doi: 10.1016/j.breast.2016.11.009
- Zhan QH, Fu JQ, Fu FM, Zhang J, Wang C. Survival and time to initiation of adjuvant chemotherapy among breast cancer patients: a systematic review and meta-analysis. Oncotarget 2017; 9: 2739-51. doi: 10.18632/ oncotarget.23086
- Flores-Balcázar CH, Flores-Luna L, Villarreal-Garza C, Mota-García A, Bargalló-Rocha E. Impact of delayed adjuvant radiotherapy in the survival of women with breast cancer. Cureus 2018; 10: e3071. doi: 10.7759/ cureus.3071
- WHO. Handbook for reporting results of cancer treatment Geneva: World Health Organisation Offset Publication; 1979. p. 48.
- Ollivier L, Padhani AR, Leclere J. International criteria for measurement tumor response. Cancer Imaging 2001; 2: 31-2. doi: 10.1102/1470-7330.2001.017
- Subbiah V, Chuang HH, Gambhire D, Kairemo K. Defining clinical response criteria and early response criteria for precision oncology: current state-of-the-art and future perspective. Diagnostics (Basel) 2017; 7: pii: E10. doi: 10.3390/diagnostics7010010
- Lafranconi A, Pylkkänen L, Deandra S, Bramesfeld A, Lerda D, Neamtiu L, et al. Intensive follow-up for women with breast cancer: review of clinical, economic and patient’s preference domains through evidence to decision framework. Health Qual Life Outcomes 2017; 15: 206. doi 10.1186/s12955-017-0779-5
- Lu WL, Jansen L, Post WJ, Bonnema J, Van de Velde JC, De Bock GH. Impact on survival of early detection of isolated breast recurrences after the primary treatment for breast cancer: a meta-analysis. Breast Cancer Res Treat 2009; 3: 403-12. doi: 10.1007/s10549-008-0023-4
- De Bock GH, Bonnema J, Van der Hage J, Kievit J, Van de Velde CJ. Effectiveness of routine visits and routine tests in detecting isolated locoregional recurrences after treatment for early-stage invasive breast cancer: a meta-analysis and systematic review. J Clin Oncol 2004; 22: 4010-8. doi: 10.1200/JCO.2004.06.080
- Feiten S, Dünnebacke J, Friesenhahn V, Heymanns J, Köppler H, Meister R, et al. Follow-up reality for breast cancer patients – standardised survey of patients and physicians and analysis of treatment data. Geburtshilfe Frauenheilkd 2016; 5: 557-63. doi: 10.1055/s-0042-106210
- Chopra I, Chopra A. Follow-up care for breast cancer survivors: improving patient outcomes. Patient Relat Outcome Meas 2014; 5: 71-85. doi: 10.2147/PROM.S49586